Circulating adipocyte fatty acid-binding protein is a predictor of cardiovascular events in patients with stable angina undergoing percutaneous coronary intervention

被引：13

作者：

Takagi, Wataru ^{[1
]}

Miyoshi, Toru ^{[2
]}

Doi, Masayuki ^{[1
]}

Okawa, Keisuke ^{[1
]}

Nosaka, Kazumasa ^{[1
]}

Nishibe, Tomoyuki ^{[1
]}

Matsuo, Naoaki ^{[1
]}

Hirohata, Satoshi ^{[3
]}

Ito, Hiroshi ^{[2
]}

机构：

[1] Kagawa Prefectural Cent Hosp, Dept Cardiol, Takamatsu, Kagawa, Japan

[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, 2-5-1 Shikata Cho, Okayama 7008558, Japan

[3] Okayama Univ, Grad Sch Hlth, Dept Med Technol, Okayama, Japan

来源：

BMC CARDIOVASCULAR DISORDERS | 2017年 / 17卷

关键词：

Adipocyte; Fatty acid; Coronary artery disease; Risk factor; ARTERY-DISEASE; HEART-DISEASE; FABP4; LEVEL; AP2; ATHEROSCLEROSIS; ASSOCIATION; INDIVIDUALS; REDUCTION; INHIBITOR; CELLS;

D O I：

10.1186/s12872-017-0691-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: Adipocyte fatty acid-binding protein (A-FABP) is expressed in both adipocytes and macrophages. Recent studies have shown that A-FABP is secreted by adipocytes and that the A-FABP concentration is associated with obesity, insulin resistance, and atherosclerosis. We have reported that the coronary atherosclerotic burden is associated with the serum A-FABP concentration. In the present study, we investigated whether the serum A-FABP concentration is associated with prognosis in patients with stable angina pectoris who have undergone percutaneous coronary intervention (PCI). Methods: This was a prospective single-center trial. In total, 130 patients with stable angina pectoris undergoing their first PCI were enrolled from August 2008 to July 2010 at Kagawa Prefectural Central Hospital. The primary endpoints were cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, revascularization, and hospitalization for heart failure. Results: During the follow-up (median, 50 months; interquartile range, 23-66 months), 49 cardiovascular events occurred. Kaplan-Meier analysis showed that the cumulative incidence of the primary endpoints in the high AFABP group (median A-FABP concentration of >= 18.6 ng/ml) was greater than that in the low A-FABP group. Cox analysis showed that the A-FABP concentration was an independent predictor of cardiovascular events adjusted for age and the presence of multi-vessel disease (hazard ratio, 1.03; 95% confidence interval, 1.01-1.04; p = 0.01). Conclusion: The serum A-FABP concentration is associated with prognosis in patients with stable angina undergoing PCI, suggesting that the serum A-FABP concentration could be useful for risk assessment of secondary prevention.

引用

页数：8

共 33 条

[11] Possible Increase in Serum FABP4 Level Despite Adiposity Reduction by Canagliflozin, an SGLT2 Inhibitor [J].

Furuhashi, Masato ;

Matsumoto, Megumi ;

Hiramitsu, Shinya ;

Omori, Akina ;

Tanaka, Marenao ;

Moniwa, Norihito ;

Yoshida, Hideaki ;

Ishii, Junnichi ;

Miura, Tetsuji .

PLOS ONE, 2016, 11 (04)

[12] Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis [J].

Furuhashi, Masato ;

Fuseya, Takahiro ;

Murata, Masaki ;

Hoshina, Kyoko ;

Ishimura, Shutaro ;

Mita, Tomohiro ;

Watanabe, Yuki ;

Omori, Akina ;

Matsumoto, Megumi ;

Sugaya, Takeshi ;

Oikawa, Tsuyoshi ;

Nishida, Junichi ;

Kokubu, Nobuaki ;

Tanaka, Marenao ;

Moniwa, Norihito ;

Yoshida, Hideaki ;

Sawada, Norimasa ;

Shimamoto, Kazuaki ;

Miura, Tetsuji .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (05) :825-834

[13] Reduction of circulating FABP4 level by treatment with omega-3 fatty acid ethyl esters [J].

Furuhashi, Masato ;

Hiramitsu, Shinya ;

Mita, Tomohiro ;

Omori, Akina ;

Fuseya, Takahiro ;

Ishimura, Shutaro ;

Watanabe, Yuki ;

Hoshina, Kyoko ;

Matsumoto, Megumi ;

Tanaka, Marenao ;

Moniwa, Norihito ;

Yoshida, Hideaki ;

Ishii, Junnichi ;

Miura, Tetsuji .

LIPIDS IN HEALTH AND DISEASE, 2016, 15

[14] Reduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus [J].

Furuhashi, Masato ;

Hiramitsu, Shinya ;

Mita, Tomohiro ;

Fuseya, Takahiro ;

Ishimura, Shutaro ;

Omori, Akina ;

Matsumoto, Megumi ;

Watanabe, Yuki ;

Hoshina, Kyoko ;

Tanaka, Marenao ;

Moniwa, Norihito ;

Yoshida, Hideaki ;

Ishii, Junnichi ;

Miura, Tetsuji .

JOURNAL OF LIPID RESEARCH, 2015, 56 (12) :2372-2380

[15] Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease [J].

Furuhashi, Masato ;

Ishimura, Shutaro ;

Ota, Hideki ;

Hayashi, Manabu ;

Nishitani, Takahiro ;

Tanaka, Marenao ;

Yoshida, Hideaki ;

Shimamoto, Kazuaki ;

Hotamisligil, Goekhan S. ;

Miura, Tetsuji .

PLOS ONE, 2011, 6 (11)

[16] FABP4 Induces Vascular Smooth Muscle Cell Proliferation and Migration through a MAPK-Dependent Pathway [J].

Girona, Josefa ;

Rosales, Roser ;

Plana, Nuria ;

Saavedra, Paula ;

Masana, Lluis ;

Vallve, Joan-Carles .

PLOS ONE, 2013, 8 (11)

[17] A PRIMARY MESOTHELIOMA INVOLVING RECTOVAGINAL SEPTUM AND ASSOCIATED WITH BERYLLIUM [J].

GOLD, C .

JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1967, 93 (02) :435-+

[18] 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards ( Writing Committee to Develop Cardiovascular Endpoints Data Standards) [J].

Hicks, Karen A. ;

Tcheng, James E. ;

Bozkurt, Biykem ;

Chaitman, Bernard R. ;

Cutlip, Donald E. ;

Farb, Andrew ;

Fonarow, Gregg C. ;

Jacobs, Jeffrey P. ;

Jaff, Michael R. ;

Lichtman, Judith H. ;

Limacher, Marian C. ;

Mahaffey, Kenneth W. ;

Mehran, Roxana ;

Nissen, Steven E. ;

Smith, Eric E. ;

Targum, Shari L. ;

Weintraub, William S. ;

Bozkurt, Biykem ;

Fonarow, Gregg C. ;

Hendel, Robert C. ;

Jacobs, Jeffrey P. ;

Jneid, Hani H. ;

Kutcher, Michael A. ;

Lichtman, Judith H. ;

Smith, Eric E. ;

Tcheng, James E. ;

Wang, Tracy Y. .

CIRCULATION, 2015, 132 (04) :302-361

[19] Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein [J].

Hotamisligil, GS ;

Johnson, RS ;

Distel, RJ ;

Ellis, R ;

Papaioannou, VE ;

Spiegelman, BM .

SCIENCE, 1996, 274 (5291) :1377-1379

[20] Elevated serum adipocyte fatty acid-binding protein concentrations are independently associated with renal dysfunction in patients with stable angina pectoris [J].

Iwamoto, Mutsumi ;

Miyoshi, Toru ;

Doi, Masayuki ;

Takeda, Ko ;

Kajiya, Masahito ;

Nosaka, Kazumasa ;

Nakayama, Rie ;

Hirohata, Satoshi ;

Usui, Shinichi ;

Kusachi, Shozo ;

Sakane, Kosuke ;

Nakamura, Kazuhfumi ;

Ito, Hiroshi .

CARDIOVASCULAR DIABETOLOGY, 2012, 11

← 1 2 3 4 →